---
schema_version: "secwatch.filing_event.v1"
accession: "0001808805-23-000073"
form_type: "8-K"
ticker: "NAUT"
cik: "0001808805"
company_name: "Nautilus Biotechnology, Inc."
filed_at: "2023-10-31T23:59:59+00:00"
generated_at: "2026-06-09T04:52:35.424482+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Nautilus Biotechnology Q3 net loss $15.9M, op ex up 21% YoY to $19.1M

## Summary
- Net loss of $15.9M for Q3 2023 vs. $14.1M in Q3 2022.
- Operating expenses rose 21% YoY to $19.1M, driven by increased headcount for product development.
- Cash, cash equivalents and investments totaled $275.7M as of Sept. 30, 2023.
- Company reiterates focus on commercial platform launch in 2024.

## SEC filing metadata
- accession: 0001808805-23-000073
- form_type: 8-K
- ticker: NAUT
- cik: 0001808805
- company_name: Nautilus Biotechnology, Inc.
- filed_at: 2023-10-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000073/0001808805-23-000073-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000073/naut-20231031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001808805-23-000073
- JSON: https://secwatch.observer/filing/0001808805-23-000073.json
- Plain text: https://secwatch.observer/filing/0001808805-23-000073.txt

## Key facts
- Earnings Releases
  Nautilus Biotechnology, Inc. reported the third quarter ended September 30, 2023 results: net income $15.9 million.
  - Period: the third quarter ended September 30, 2023
  - Net income: $15.9 million
  - Result: reported results
  source text: Net loss was $15.9 million for the third quarter of 2023, as compared to a net loss of $14.1 million for the corresponding prior year period.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808805/000180880523000073/0001808805-23-000073-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.